3.010USD-0.33%Mkt Cap: 278.94M USDP/E: —Last update: 2026-06-01
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and r…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap278.94M USD
Enterprise Value149.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-46.38M USD
Revenue/Share—
Last Price3.010 USD
Fiscal Year EndSep 2025
MR QuarterDec 2025
Employees34
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0327973006
Valuation
P/E (Trailing)—
P/E (Forward)-5.51
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.22
EPS (TTM)-0.46
EPS (Forward)-0.55
52W Range
2.6104% of range13.99
52W High13.99 USD
52W Low2.610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-48.89%
ROA-44.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.04M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-7.83%
Net Debt-131.75M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio20.87
Quick Ratio20.81
Book Value/Sh1.366 USD
Cash/Share1.422 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateOct 7, 2015
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)20.00 USD
Target Range20.00 USD – 20.00 USD
# Analysts1
Ownership
Shares Out.92.67M
Float89.78M
Insiders3.12%
Institutions43.73%
Short Interest
Short Ratio21.0d
Short % Float21.60%
Short % Out.20.75%
Shares Short19.23M
Short (prev mo.)18.95M
Technical
SMA 503.222 (-6.6%)
SMA 2005.539 (-45.7%)
Beta1.25
S&P 52W Chg27.94%
Avg Vol (30d)911.01K
Avg Vol (10d)1.14M
Technical Indicators
RSI (14)48.9
MACD-0.1478
MACD Signal-0.1621
MACD Hist.+0.0143
BB Upper3.516 USD
BB Middle3.008 USD
BB Lower2.501 USD
BB Width33.73%
ATR (14)0.1856 USD
Vol Ratio (20d)0.86x